Bank Hapoalim BM’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-4,168
Closed -$543K 186
2022
Q1
$543K Sell
4,168
-2,697
-39% -$351K 0.06% 154
2021
Q4
$1.05M Sell
6,865
-381
-5% -$59K 0.11% 131
2021
Q3
$1.17M Sell
7,246
-21
-0.3% -$3.53K 0.12% 118
2021
Q2
$1.19M Sell
7,267
-21
-0.3% -$3.23K 0.13% 117
2021
Q1
$1.1M Buy
7,288
+11
+0.2% +$1.75K 0.14% 113
2020
Q4
$1.1M Buy
7,277
+91
+1% +$13K 0.15% 95
2020
Q3
$973 Sell
7,186
-170
-2% -$23.1K 0.05% 83
2020
Q2
$1M Buy
7,356
+971
+15% +$124K 0.24% 78
2020
Q1
$688K Sell
6,385
-975
-13% -$112K 0.22% 83
2019
Q4
$887K Sell
7,360
-714
-9% -$79.7K 0.19% 77
2019
Q3
$802K Sell
8,074
-287
-3% -$30K 0.2% 75
2019
Q2
$912K Sell
8,361
-308
-4% -$32.8K 0.22% 75
2019
Q1
$969K Buy
8,669
+1,023
+13% +$112K 0.23% 71
2018
Q4
$737K Sell
7,646
-1,042
-12% -$111K 0.24% 74
2018
Q3
$1.06M Sell
8,688
-120
-1% -$14.1K 0.26% 74
2018
Q2
$967K Sell
8,808
-1,416
-14% -$151K 0.26% 77
2018
Q1
$1.09M Sell
10,224
-8,910
-47% -$988K 0.28% 72
2017
Q4
$2.04K Sell
19,134
-1,323
-6% -$141K 0.45% 46
2017
Q3
$2.27M Buy
20,457
+507
+3% +$54.2K 0.52% 45
2017
Q2
$2.06M Buy
19,950
+4,557
+30% +$449K 0.49% 47
2017
Q1
$1.5M Sell
15,393
-4,911
-24% -$470K 0.35% 63
2016
Q4
$1.8M Buy
20,304
+1,278
+7% +$116K 0.48% 48
2016
Q3
$1.84M Buy
19,026
+1,182
+7% +$112K 0.43% 53
2016
Q2
$1.53M Buy
17,844
+11,343
+174% +$1.02M 0.36% 62
2016
Q1
$565K Buy
6,501
+933
+17% +$83.4K 0.13% 100
2015
Q4
$628K Buy
5,568
+237
+4% +$25.7K 0.14% 97
2015
Q3
$539K Sell
5,331
-7,716
-59% -$925K 0.13% 103
2015
Q2
$1.6M Sell
13,047
-70,629
-84% -$8.45M 0.31% 58
2015
Q1
$2.24M Buy
83,676
+70,080
+515% +$7.73M 0.41% 52
2014
Q4
$1.38M Buy
13,596
+1,119
+9% +$109K 0.29% 61
2014
Q3
$1.14M Buy
12,477
+6,003
+93% +$527K 0.26% 67
2014
Q2
$555K Buy
6,474
+2,415
+59% +$190K 0.14% 96
2014
Q1
$320K Buy
+4,059
New +$338K 0.09% 110

Other funds holding IBB